Glenview State Bank Trust DEPT. Has $277,000 Position in GlaxoSmithKline PLC (GSK)

Glenview State Bank Trust DEPT. maintained its position in GlaxoSmithKline PLC (NYSE:GSK) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,400 shares of the pharmaceutical company’s stock at the end of the second quarter. Glenview State Bank Trust DEPT.’s holdings in GlaxoSmithKline PLC were worth $277,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of GSK. Cribstone Capital Management LLC purchased a new position in GlaxoSmithKline PLC during the second quarter worth approximately $117,000. Quadrant Capital Group LLC increased its position in GlaxoSmithKline PLC by 6.4% in the second quarter. Quadrant Capital Group LLC now owns 2,725 shares of the pharmaceutical company’s stock worth $111,000 after buying an additional 163 shares during the period. Williams Jones & Associates LLC purchased a new position in GlaxoSmithKline PLC during the first quarter worth approximately $161,000. LS Investment Advisors LLC increased its position in GlaxoSmithKline PLC by 167.5% in the second quarter. LS Investment Advisors LLC now owns 4,280 shares of the pharmaceutical company’s stock worth $185,000 after buying an additional 2,680 shares during the period. Finally, Cape Cod Five Cents Savings Bank acquired a new position in shares of GlaxoSmithKline PLC during the second quarter worth about $201,000. Institutional investors and hedge funds own 8.79% of the company’s stock.

Institutional Ownership by Quarter for GlaxoSmithKline PLC (NYSE:GSK)

GlaxoSmithKline PLC (NYSE:GSK) traded down 1.67% on Friday, reaching $41.68. 3,538,625 shares of the company’s stock traded hands. GlaxoSmithKline PLC has a 52-week low of $37.82 and a 52-week high of $45.58. The firm’s 50 day moving average price is $43.15 and its 200 day moving average price is $42.93. The firm has a market capitalization of $101.30 billion, a PE ratio of 2605.00 and a beta of 0.89.

The company also recently declared a dividend, which was paid on Thursday, October 13th. Shareholders of record on Friday, August 12th were given a $0.494 dividend. The ex-dividend date was Wednesday, August 10th. GlaxoSmithKline PLC’s dividend payout ratio (DPR) is presently 6,166.67%.

A number of brokerages have issued reports on GSK. Beaufort Securities reissued a “buy” rating on shares of GlaxoSmithKline PLC in a report on Tuesday, August 2nd. Shore Capital reissued a “hold” rating on shares of GlaxoSmithKline PLC in a report on Wednesday, July 27th. Goldman Sachs Group Inc. reissued a “buy” rating on shares of GlaxoSmithKline PLC in a report on Thursday, July 28th. BNP Paribas reissued a “neutral” rating on shares of GlaxoSmithKline PLC in a report on Sunday, July 31st. Finally, Citigroup Inc. reissued a “buy” rating on shares of GlaxoSmithKline PLC in a report on Wednesday, August 10th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $47.86.

About GlaxoSmithKline PLC

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

5 Day Chart for NYSE:GSK

Want to see what other hedge funds are holding GSK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GlaxoSmithKline PLC (NYSE:GSK).

Receive News & Ratings for GlaxoSmithKline PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Disney to Build Larger Hong Kong Kingdom
Disney to Build Larger Hong Kong Kingdom


 
© 2006-2016 Ticker Report. Google+.